These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 17222056)

  • 1. Both ligand- and cell-specific parameters control ligand agonism in a kinetic model of g protein-coupled receptor signaling.
    Kinzer-Ursem TL; Linderman JJ
    PLoS Comput Biol; 2007 Jan; 3(1):e6. PubMed ID: 17222056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A kinetic model of GPCRs: analysis of G protein activity, occupancy, coupling and receptor-state affinity constants.
    Stein RS; Ehlert FJ
    J Recept Signal Transduct Res; 2015; 35(4):269-83. PubMed ID: 25353707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modelling and simulation of biased agonism dynamics at a G protein-coupled receptor.
    Bridge LJ; Mead J; Frattini E; Winfield I; Ladds G
    J Theor Biol; 2018 Apr; 442():44-65. PubMed ID: 29337260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy as a vector: the relative prevalence and paucity of inverse agonism.
    Kenakin T
    Mol Pharmacol; 2004 Jan; 65(1):2-11. PubMed ID: 14722230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Explicit formulation of different receptor-G-protein interactions and effector regulation.
    Kukkonen JP
    Bioinformatics; 2004 Oct; 20(15):2411-20. PubMed ID: 15087317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular dynamics simulations of the effect of the G-protein and diffusible ligands on the β2-adrenergic receptor.
    Goetz A; Lanig H; Gmeiner P; Clark T
    J Mol Biol; 2011 Dec; 414(4):611-23. PubMed ID: 22037586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function.
    Kristiansen K
    Pharmacol Ther; 2004 Jul; 103(1):21-80. PubMed ID: 15251227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.
    Bhattacharya S; Hall SE; Vaidehi N
    J Mol Biol; 2008 Oct; 382(2):539-55. PubMed ID: 18638482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An inactive receptor-G protein complex maintains the dynamic range of agonist-induced signaling.
    Jang W; Adams CE; Liu H; Zhang C; Levy FO; Andressen KW; Lambert NA
    Proc Natl Acad Sci U S A; 2020 Dec; 117(48):30755-30762. PubMed ID: 33199589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging structural insights into biased GPCR signaling.
    Shukla AK; Singh G; Ghosh E
    Trends Biochem Sci; 2014 Dec; 39(12):594-602. PubMed ID: 25458114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational complexity of G-protein-coupled receptors.
    Kobilka BK; Deupi X
    Trends Pharmacol Sci; 2007 Aug; 28(8):397-406. PubMed ID: 17629961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling and simulation of inverse agonism dynamics.
    Bridge LJ
    Methods Enzymol; 2010; 485():559-82. PubMed ID: 21050936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand- and heterodimer-directed signaling of the CB(1) cannabinoid receptor.
    Hudson BD; Hébert TE; Kelly ME
    Mol Pharmacol; 2010 Jan; 77(1):1-9. PubMed ID: 19837905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A New Molecular Mechanism To Engineer Protean Agonism at a G Protein-Coupled Receptor.
    De Min A; Matera C; Bock A; Holze J; Kloeckner J; Muth M; Traenkle C; De Amici M; Kenakin T; Holzgrabe U; Dallanoce C; Kostenis E; Mohr K; Schrage R
    Mol Pharmacol; 2017 Apr; 91(4):348-356. PubMed ID: 28167741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot the pulse: controlling the multiplicity of receptor dynamics.
    Bock A; Kostenis E; Tränkle C; Lohse MJ; Mohr K
    Trends Pharmacol Sci; 2014 Dec; 35(12):630-8. PubMed ID: 25455830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elucidating Ligand-Modulated Conformational Landscape of GPCRs Using Cloud-Computing Approaches.
    Shukla D; Lawrenz M; Pande VS
    Methods Enzymol; 2015; 557():551-72. PubMed ID: 25950981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular dynamics of a biophysical model for beta2-adrenergic and G protein-coupled receptor activation.
    Rubenstein LA; Zauhar RJ; Lanzara RG
    J Mol Graph Model; 2006 Dec; 25(4):396-409. PubMed ID: 16574446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unravelling intrinsic efficacy and ligand bias at G protein coupled receptors: A practical guide to assessing functional data.
    Stott LA; Hall DA; Holliday ND
    Biochem Pharmacol; 2016 Feb; 101():1-12. PubMed ID: 26478533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biased agonism at G protein-coupled receptors: the promise and the challenges--a medicinal chemistry perspective.
    Shonberg J; Lopez L; Scammells PJ; Christopoulos A; Capuano B; Lane JR
    Med Res Rev; 2014 Nov; 34(6):1286-330. PubMed ID: 24796277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational analysis of g protein-coupled receptor signaling by hydrogen/deuterium exchange mass spectrometry.
    Li S; Lee SY; Chung KY
    Methods Enzymol; 2015; 557():261-78. PubMed ID: 25950969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.